Search research articles
Contact Us
Filters
Showing results (951-960 of 1,095) with videos related to
Page
of 110
Sort By:
The Journal of Biological Chemistry
|
November 5, 2022
Functional divergence of the sarcomeric myosin, MYH7b, supports species-specific biological roles
Lindsey A Lee, Samantha K Barrick, Artur Meller, et al.
Contemporary Clinical Trials
|
November 3, 2022
Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial
Erika Biederman, Ryan Baltic, Mira L Katz, et al.
Plos One
|
April 10, 2019
Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways
Benjamin Stump, Shikshya Shrestha, Anthony M Lamattina, et al.
Bioorganic & Medicinal Chemistry
|
July 6, 2022
10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
Nathan S Duncan, Michael J Campbell, Donald S Backos, et al.
Journal of the American College of Cardiology
|
October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group
E J Topol, S G Ellis, R M Califf, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2023
Exploring the Chemical Properties and Medicinal Applications of Tetramethylthiocycloheptyne Sulfoximine Used in Strain-Promoted Azide-Alkyne Cycloaddition Reactions
Matt Timmers, Andi Kipper, Raphael Frey, et al.
Anesthesia and Analgesia
|
September 28, 2002
Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow
Richard C Prielipp, Michael H Wall, Joseph R Tobin, et al.
Circulation
|
January 1, 1991
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group
D C Sane, D C Stump, E J Topol, et al.
Contemporary Clinical Trials Communications
|
December 19, 2024
Challenges and lessons learned in recruiting participants for school-based disease prevention programs during COVID-19
Yelena P Wu, Elise K Brunsgaard, Nic Siniscalchi, et al.
Pediatrics
|
July 2, 2023
Preliminary Reach of an Information Technology Approach to Support COVID-19 Testing in Schools
Tammy K Stump, David W Wetter, Tatyana Kuzmenko, et al.
Page
of 110
Search research articles
Search
Showing results (951-960 of 1,095) with videos related to
Sort By:
Page
of 110
The Journal of Biological Chemistry
|
November 5, 2022
Functional divergence of the sarcomeric myosin, MYH7b, supports species-specific biological roles
Lindsey A Lee, Samantha K Barrick, Artur Meller, et al.
Contemporary Clinical Trials
|
November 3, 2022
Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial
Erika Biederman, Ryan Baltic, Mira L Katz, et al.
Plos One
|
April 10, 2019
Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways
Benjamin Stump, Shikshya Shrestha, Anthony M Lamattina, et al.
Bioorganic & Medicinal Chemistry
|
July 6, 2022
10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
Nathan S Duncan, Michael J Campbell, Donald S Backos, et al.
Journal of the American College of Cardiology
|
October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group
E J Topol, S G Ellis, R M Califf, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2023
Exploring the Chemical Properties and Medicinal Applications of Tetramethylthiocycloheptyne Sulfoximine Used in Strain-Promoted Azide-Alkyne Cycloaddition Reactions
Matt Timmers, Andi Kipper, Raphael Frey, et al.
Anesthesia and Analgesia
|
September 28, 2002
Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow
Richard C Prielipp, Michael H Wall, Joseph R Tobin, et al.
Circulation
|
January 1, 1991
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group
D C Sane, D C Stump, E J Topol, et al.
Contemporary Clinical Trials Communications
|
December 19, 2024
Challenges and lessons learned in recruiting participants for school-based disease prevention programs during COVID-19
Yelena P Wu, Elise K Brunsgaard, Nic Siniscalchi, et al.
Pediatrics
|
July 2, 2023
Preliminary Reach of an Information Technology Approach to Support COVID-19 Testing in Schools
Tammy K Stump, David W Wetter, Tatyana Kuzmenko, et al.
Page
of 110